| EV Resources Limited (EVR) ORDINARY FULLY PAID |
Materials |
$27 |
US Advisor Engaged to Accelerate Antimony Strategy
|
20 Feb 2026 9:03AM |
$0.009 |
$0.009 |
fallen by
0%
|
|
EVR - Price-sensitive ASX Announcement
Full Release
Key Points
- U.S.-based advisory firm MineMaker LLC engaged to advance North American antimony supply chain strategy.
- Focus on accelerating development of assets in Mexico and Nevada.
- MineMaker will lead engagement with U.S. federal and state agencies.
- Non-dilutive funding opportunities include the Defense Production Act and Inflation Reduction Act.
- MineMaker has a proven track record in critical minerals sector.
- EV Resources aims to become a leading near-term supplier of antimony to North America.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,703 |
Dividend/Distribution - LSF
|
20 Feb 2026 8:59AM |
$4.210 |
$4.270 |
risen by
1.43%
|
|
| Ironbark Balanced Income Limited (IBC) ORDINARY FULLY PAID |
Financials |
$45 |
Update - Notification of buy-back - IBC
|
20 Feb 2026 8:58AM |
$0.440 |
$0.440 |
fallen by
0%
|
|
| BSP Financial Group Limited (BFL) ORDINARY FULLY PAID |
Financials |
$3,995 |
BFL - Annual Report to shareholders
|
20 Feb 2026 8:57AM |
$8.530 |
$8.550 |
risen by
0.23%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$3,533 |
Appendix 4G and 2025 Corporate Governance Statement
|
20 Feb 2026 8:54AM |
$9.130 |
$10.430 |
risen by
14.24%
|
|
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$3,533 |
2025 Full Year Results Presentation
|
20 Feb 2026 8:53AM |
$9.130 |
$10.430 |
risen by
14.24%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Group revenue increased by 56% to $804 million in 2025.
- Precision Medicine revenue grew by 22% to $622 million.
- Strategic product launches of Illuccix and Gozellix were successful.
- Investment in R&D and commercial infrastructure exceeded $500 million.
- Major clinical programs include TLX591-Tx for prostate cancer and TLX101-Tx for glioblastoma.
- Telix aims for 2026 revenue of $950 million to $970 million.
- The company focuses on expanding international presence and launching new products.
- Maintained a gross margin of 53% and continued investment in manufacturing capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$3,533 |
2025 Full Year Results Announcement
|
20 Feb 2026 8:53AM |
$9.130 |
$10.430 |
risen by
14.24%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Strong commercial performance in 2025 financial year.
- Significant milestones in therapeutic pipeline and regulatory approvals.
- Revenue for 2025 was USD 803.8 million and gross profit USD 426.4 million.
- 2026 revenue guidance between USD 950 million and USD 970 million.
- Plans significant R&D investment to accelerate therapeutic pipeline.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Telix Pharmaceuticals Limited (TLX) ORDINARY FULLY PAID |
Health Care |
$3,533 |
Appendix 4E and 2025 Annual Report
|
20 Feb 2026 8:52AM |
$9.130 |
$10.430 |
risen by
14.24%
|
|
TLX - Price-sensitive ASX Announcement
Full Release
Key Points
- Telix recorded a total revenue of $803.8 million for 2025.
- There was a net loss of $7.1 million primarily due to increased R&D and operating expenditures.
- Strong sales performance in the U.S. for Illuccix and launch of Gozellix.
- Advancements in radiopharmaceutical pipeline with multiple regulatory approvals.
- Expansion of global manufacturing capabilities for future product commercialization.
- Focus on strategic areas like urologic and neurologic oncology.
- Commitment to sustainability and healthcare access, including initiatives in nuclear medicine.
- No dividends were proposed or paid for 2025.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Terragen Holdings Limited (TGH) ORDINARY FULLY PAID |
Materials |
$13 |
Notice of General Meeting/Proxy Form
|
20 Feb 2026 8:52AM |
$0.021 |
$0.020 |
fallen by
4.76%
|
|
| Newmont Corporation (NEM) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$14,677 |
Dividend/Distribution - NEM
|
20 Feb 2026 8:50AM |
$176.250 |
$167.600 |
fallen by
4.91%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$814 |
MyState Limited HY26 Results Investor Presentation
|
20 Feb 2026 8:50AM |
$4.780 |
$4.800 |
risen by
0.42%
|
|
MYS - Price-sensitive ASX Announcement
Full Release
Key Points
- MyState Limited (MYS) is a diversified financial services group listed in September 2009.
- MYS merged with Auswide Bank in February 2025.
- The company provides banking, trustee, equipment finance, and wealth management services.
- MYS operates through MyState Bank, Auswide Bank, Selfco, and TPT Wealth.
- MyState reported strong earnings growth in 1H26.
- Statutory net profit after tax increased 71.4% compared to 1H25.
- Underlying earnings per share increased by 5.4%.
- Net interest income increased by 12%.
- Customer deposits and home loan book both showed growth.
- MYS remains well-capitalized with strong capital ratios.
- The interim dividend was raised to 12.0 cps, fully franked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| L1 Long Short Fund Limited (LSF) ORDINARY FULLY PAID |
Financials |
$2,703 |
Results for Half Year Ended 31 December 2025
|
20 Feb 2026 8:49AM |
$4.210 |
$4.270 |
risen by
1.43%
|
|
LSF - Price-sensitive ASX Announcement
Full Release
Key Points
- The interim financial report complies with Australian Accounting Standards and the Corporations Act 2001.
- The performance fees incurred during the period amounted to $151,075,000.
- The company aims for positive absolute returns while preserving capital.
- The financial position as of 31 December 2025 shows a strong balance sheet.
- A fully franked interim dividend of 3.50 cents per share was declared during the period.
- The report underscores the continuous compliance with statutory requirements.
- The directors are responsible for ensuring the interim financial report provides a true and fair view.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cadoux Limited (CCM) ORDINARY FULLY PAID |
Materials |
$13 |
Cadoux SAFELOOP General Meeting Assembly Meeting Abstract
|
20 Feb 2026 8:49AM |
$0.035 |
$0.035 |
fallen by
0%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$814 |
MyState Limited HY26 Results Announcement
|
20 Feb 2026 8:46AM |
$4.780 |
$4.800 |
risen by
0.42%
|
|
MYS - Price-sensitive ASX Announcement
Full Release
Key Points
- MyState Limited's total operating income for 1H26 increased by 14.1% to $125.2 million.
- Statutory net profit after tax rose by 39% to $27.3 million.
- Integration synergies of $10.4 million achieved; targeting $20-$25 million by FY28.
- Home loans reached $12.9 billion with strong application momentum.
- Selfco's equipment finance portfolio grew by 64% to $261 million.
- A new online savings account, 'Hello Saver', was launched.
- An interim dividend of 12.0 cents per share was declared.
- Total capital ratio was 16.9%, down due to Tier 2 note redemptions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AusGold Limited (AUC) ORDINARY FULLY PAID |
Materials |
$581 |
Financial Report for the half-year ended 31 December 2025
|
20 Feb 2026 8:46AM |
$1.045 |
$1.060 |
risen by
1.44%
|
|
| Qube Holdings Limited (QUB) ORDINARY FULLY PAID |
Industrials |
$8,957 |
Half Year Investor Presentation
|
20 Feb 2026 8:45AM |
$5.060 |
$5.060 |
fallen by
0%
|
|
QUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Qube Holdings Limited experienced a 12.9% increase in underlying revenue, reaching $2,359.4 million in the first half of FY26.
- Underlying EBITDA rose by 7.0% to $319.2 million, and EBITA increased by 9.8% to $196.3 million during the same period.
- The company declared a fully franked interim dividend of 5.35 cents per share, which is a 30.5% increase from H1 FY25.
- Qube's Logistics & Infrastructure unit saw revenue growth of 24.4%, largely driven by grain trading activities.
- Ports & Bulk division experienced flat revenue growth, with significant earnings from the energy sector and new contracts in bulk activities.
- Qube's financial position benefited from asset sales, contributing to a reduction in net debt.
- A significant development was the announcement of a Scheme Implementation Deed with a consortium led by Macquarie Asset Management to acquire all issued shares in Qube.
- The board recommends shareholders accept the scheme, pending necessary approvals and conditions.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$814 |
Dividend/Distribution - MYS
|
20 Feb 2026 8:44AM |
$4.780 |
$4.800 |
risen by
0.42%
|
|
| MyState Limited (MYS) ORDINARY FULLY PAID |
Financials |
$814 |
Half Yearly Report and Accounts
|
20 Feb 2026 8:44AM |
$4.780 |
$4.800 |
risen by
0.42%
|
|
MYS - Price-sensitive ASX Announcement
Full Release
Key Points
- Statutory NPAT increased by 71.4% on 1HY25.
- Statutory earnings per share increased by 12.1%.
- Return on equity improved to 7.4%.
- Integration of Auswide Bank continues to enhance operations.
- Loan book of $13.25 billion reported.
- Total comprehensive income of $23.133 million.
- High customer net promoter score of +65 maintained.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$8,681 |
FY26 Interim Dividend and DRP
|
20 Feb 2026 8:42AM |
$4.510 |
$4.510 |
fallen by
0%
|
|
RMS - Price-sensitive ASX Announcement
Full Release
Key Points
- Ramelius Resources Limited announced a fully franked interim dividend of A$0.03 per share.
- Dividend relates to half year ending 31 December 2025.
- Ex-Dividend Date is 16 March 2026.
- Record Date is 17 March 2026.
- Final date to participate in DRP is 18 March 2026.
- No discount applies to shares under DRP.
- DRP price based on ASX volume-weighted average price.
- No transaction costs for DRP participation.
- International offer restrictions apply to non-Australian/New Zealand shareholders.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$373 |
H1 FY26 Results Presentation
|
20 Feb 2026 8:41AM |
$3.500 |
$3.610 |
risen by
3.14%
|
|
LGI - Price-sensitive ASX Announcement
Full Release
Key Points
- Significant increase in biogas flows and ACCU creation.
- Statutory revenue rose by 20.2%.
- EBITDA increased by 33.1%.
- Project pipeline expanded to exceed 80MWs.
- Full payment of debt facility achieved.
- Regulatory updates provide clarity for carbon credit schemes.
- Focus on leveraging vertically integrated model for growth.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$373 |
H1 FY26 Results Announcement
|
20 Feb 2026 8:39AM |
$3.500 |
$3.610 |
risen by
3.14%
|
|
LGI - Price-sensitive ASX Announcement
Full Release
Key Points
- LGI Limited's revenue increased by 20% in H1 FY26.
- EBITDA grew by 33% over the corresponding period.
- Biogas flows increased by 37% and renewable energy generation by 41%.
- 270,711 Australian Carbon Credit Units were created, up 19%.
- An interim dividend of 1.25 cents per share was announced.
- A capital raising of over $56 million was achieved to expand project capacity.
- LGI reaffirms FY26 guidance with an expected EBITDA growth of 25% to 30%.
- Strategic growth in High Conviction Projects to exceed 80MW.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Qube Holdings Limited (QUB) ORDINARY FULLY PAID |
Industrials |
$8,957 |
Half Year Results Announcement
|
20 Feb 2026 8:37AM |
$5.060 |
$5.060 |
fallen by
0%
|
|
QUB - Price-sensitive ASX Announcement
Full Release
Key Points
- Underlying revenue up 12.9% to $2.36 billion.
- Underlying earnings (EBITA) up nearly 10% to $196.3 million.
- Interim dividend increased by 30.5% to 5.35 cents per share.
- Positive contributions from recent acquisitions.
- Diversification strategy enhanced earnings growth.
- Transaction with Macquarie Asset Management to acquire 100% of shares.
- Expectation of continued solid earnings growth in FY26.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Ramelius Resources Limited (RMS) ORDINARY FULLY PAID |
Materials |
$8,681 |
H1 FY26 Financial Results Presentation
|
20 Feb 2026 8:37AM |
$4.510 |
$4.510 |
fallen by
0%
|
|
RMS - Price-sensitive ASX Announcement
Full Release
Key Points
- EBITDA increased by 35% to A$369.7 million.
- Gold production decreased by 7% to 101,000 ounces.
- Realized gold price rose by 36% to A$4,822 per ounce.
- Acquisition of Spartan impacted financial results.
- AISC increased by 38% to A$1,901 per ounce.
- Continued focus on growth projects and exploration.
- Strong liquidity with A$694.3 million in cash and gold.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Peter Warren Automotive Holdings Limited (PWR) ORDINARY FULLY PAID |
Consumer Discretionary |
$276 |
H1 FY26 Results Presentation
|
20 Feb 2026 8:37AM |
$1.730 |
$1.600 |
fallen by
7.51%
|
|
PWR - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue of $1,268 million in H1 FY26.
- Gross profit of $205 million with a stable margin of 16.2%.
- PBT increased by 76.1% to $12.5 million.
- Operating expenses reduced to 11.9% of revenue.
- Wakeling Automotive acquisition to increase revenue by 20%.
- Focus on customer-centric culture and leveraging technology.
- Continued growth in earnings and disciplined cost management.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| AdAlta Limited (1AD) ORDINARY FULLY PAID |
Health Care |
$8 |
Half Yearly Report and Accounts
|
20 Feb 2026 8:37AM |
$0.004 |
$0.003 |
fallen by
25%
|
|
1AD - Price-sensitive ASX Announcement
Full Release
Key Points
- Net liabilities of $218,656 as of 31 December 2025
- Issued capital increased to $51,974,224
- Recorded losses of $2,437,141 after income tax for the half-year
- Share-based payments and conversion of investment agreements contributed to capital
- Total deficiency in equity improved compared to previous period
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
Call 1300 880 160
Start a chat
Schedule a call
